1-6 of 6
Weiming Xu
Close
Save search
Sort by
Journal Articles

Optec: A Phase 2 Study to Evaluate Outpatient Step-up Administration of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results

Free
Robert Rifkin, Henning Schade, Gary Simmons, Christopher Yasenchak, Jessica Fowler, Thomas S. Lin, Lijuan Kang, Weiming Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4753.
https://doi.org/10.1182/blood-2024-207295
Published: 2024
Journal Articles

Efficacy and Safety of Single-Agent Zandelisib Administered By Intermittent Dosing in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Final Results of the Tidal Phase 2 Study

Free
Andrew D. Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim M. Linton, Graham P. Collins, Mark Bishton, Javier López Jiménez, Bhagirathbhai Dholaria, Andrea Mengarelli, Tycel J. Phillips, Nagendra Prasad Sungala, Henry Chan, Gerardo Musuraca, Oonagh Sheehy, Junyi Yan, Weiming Xu, Michel Azoulay, Pier Luigi Zinzani
Journal: Blood
Blood (2022) 140 (Supplement 1): 3595–3597.
https://doi.org/10.1182/blood-2022-165409
Published: 2022
Journal Articles

Coastal: A Phase 3 Study of the PI3Kδ Inhibitor Zandelisib with Rituximab (R) Versus Immunochemotherapy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Free
Wojciech Jurczak, Pier Luigi Luigi Zinzani, David Cunningham, Michel Azoulay, Wenying Huang, Weiming Xu, Vincent Ribrag
Journal: Blood
Blood (2021) 138 (Supplement 1): 2430.
https://doi.org/10.1182/blood-2021-148015
Published: 2021
Journal Articles

A Novel mTOR Kinase Inhibitor Causes Growth Inhibition, Cell Cycle Arrest, Apoptosis and Autophagic Cell Death in Mantle Cell Lymphoma Cell Lines: A Distinct Profile from Rapamycin.

Free
Weiming Xu, Christine Kang, Mercedes Delgado, Sophie M Perrin-Ninkovic, Patrick W Papa, Jennifer R Riggs, John Sapienza, Ronald J Albers, Branden G.S Lee, Roy L Harris, Deborah S Mortensen, Peter Worland, Sabita Sankar
Journal: Blood
Blood (2008) 112 (11): 1579.
https://doi.org/10.1182/blood.V112.11.1579.1579
Published: 2008
Journal Articles

Targeting the p27 E3 ligase SCF Skp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy

Free
Qing Chen, Weilin Xie, Deborah J. Kuhn, Peter M. Voorhees, Antonia Lopez-Girona, Derek Mendy, Laura G. Corral, Veronique Plantevin Krenitsky, Weiming Xu, Laure Moutouh-de Parseval, David R. Webb, Frank Mercurio, Keiichi I. Nakayama, Keiko Nakayama, Robert Z. Orlowski
Journal: Blood
Blood (2008) 111 (9): 4690–4699.
https://doi.org/10.1182/blood-2007-09-112904
Published: 2008
Includes: Supplemental data
Journal Articles

Targeting the p27 Kip1 E3 Ubiquitin Ligase for the Treatment of Multiple Myeloma and Other Hematological Malignancies.

Free
Qing Chen, PhD, Weilin Xie, PhD, Deborah J. Kuhn, PhD, Peter M. Voorhees, MD, Derek Mendy, MD, Antonia Lopez-Girona, PhD, Veronique Plantevin, PhD, Weiming Xu, PhD, Laura De Parseval, PhD, Laura G. Corral, PhD, Emilia Glezer, PhD, Kyle Chan, PhD, Frank Mercurio, PhD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 372.
https://doi.org/10.1182/blood.V108.11.372.372
Published: 2006